Global Recombinant Human Parathyroid Hormone Market Research Report 2024(Status and Outlook)
Report Overview:
Recombinant Human Parathyroid Hormone is an artificially manufactured form of the parathyroid hormone used to treat hypoparathyroidism. Recombinant human parathyroid hormone is used in the treatment of osteoporosis in postmenopausal women at high risk of osteoporotic fractures. A significant reduction in the incidence of vertebral fractures has been demonstrated.
The Global Recombinant Human Parathyroid Hormone Market Size was estimated at USD 154.30 million in 2023 and is projected to reach USD 228.98 million by 2029, exhibiting a CAGR of 6.80% during the forecast period.
This report provides a deep insight into the global Recombinant Human Parathyroid Hormone market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Recombinant Human Parathyroid Hormone Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Recombinant Human Parathyroid Hormone market in any manner.
Global Recombinant Human Parathyroid Hormone Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
NPS Pharma(Shire)
Takeda
Shandong Buchang Pharmaceuticals
Ascendis Pharma
Beijing SL Pharmaceutical
Market Segmentation (by Type)
25 mcg/dose
50 mcg/dose
75 mcg/dose
100 mcg/dose
Market Segmentation (by Application)
Postmenopausal Women with Osteoporosis
Hypocalcemia in Patients with Hypoparathyroidism
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Recombinant Human Parathyroid Hormone Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Recombinant Human Parathyroid Hormone is an artificially manufactured form of the parathyroid hormone used to treat hypoparathyroidism. Recombinant human parathyroid hormone is used in the treatment of osteoporosis in postmenopausal women at high risk of osteoporotic fractures. A significant reduction in the incidence of vertebral fractures has been demonstrated.
The Global Recombinant Human Parathyroid Hormone Market Size was estimated at USD 154.30 million in 2023 and is projected to reach USD 228.98 million by 2029, exhibiting a CAGR of 6.80% during the forecast period.
This report provides a deep insight into the global Recombinant Human Parathyroid Hormone market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Recombinant Human Parathyroid Hormone Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Recombinant Human Parathyroid Hormone market in any manner.
Global Recombinant Human Parathyroid Hormone Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
NPS Pharma(Shire)
Takeda
Shandong Buchang Pharmaceuticals
Ascendis Pharma
Beijing SL Pharmaceutical
Market Segmentation (by Type)
25 mcg/dose
50 mcg/dose
75 mcg/dose
100 mcg/dose
Market Segmentation (by Application)
Postmenopausal Women with Osteoporosis
Hypocalcemia in Patients with Hypoparathyroidism
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Recombinant Human Parathyroid Hormone Market
- Overview of the regional outlook of the Recombinant Human Parathyroid Hormone Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Recombinant Human Parathyroid Hormone Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Recombinant Human Parathyroid Hormone
1.2 Key Market Segments
1.2.1 Recombinant Human Parathyroid Hormone Segment by Type
1.2.2 Recombinant Human Parathyroid Hormone Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 RECOMBINANT HUMAN PARATHYROID HORMONE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Recombinant Human Parathyroid Hormone Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Recombinant Human Parathyroid Hormone Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 RECOMBINANT HUMAN PARATHYROID HORMONE MARKET COMPETITIVE LANDSCAPE
3.1 Global Recombinant Human Parathyroid Hormone Sales by Manufacturers (2019-2024)
3.2 Global Recombinant Human Parathyroid Hormone Revenue Market Share by Manufacturers (2019-2024)
3.3 Recombinant Human Parathyroid Hormone Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Recombinant Human Parathyroid Hormone Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Recombinant Human Parathyroid Hormone Sales Sites, Area Served, Product Type
3.6 Recombinant Human Parathyroid Hormone Market Competitive Situation and Trends
3.6.1 Recombinant Human Parathyroid Hormone Market Concentration Rate
3.6.2 Global 5 and 10 Largest Recombinant Human Parathyroid Hormone Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 RECOMBINANT HUMAN PARATHYROID HORMONE INDUSTRY CHAIN ANALYSIS
4.1 Recombinant Human Parathyroid Hormone Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF RECOMBINANT HUMAN PARATHYROID HORMONE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 RECOMBINANT HUMAN PARATHYROID HORMONE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Recombinant Human Parathyroid Hormone Sales Market Share by Type (2019-2024)
6.3 Global Recombinant Human Parathyroid Hormone Market Size Market Share by Type (2019-2024)
6.4 Global Recombinant Human Parathyroid Hormone Price by Type (2019-2024)
7 RECOMBINANT HUMAN PARATHYROID HORMONE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Recombinant Human Parathyroid Hormone Market Sales by Application (2019-2024)
7.3 Global Recombinant Human Parathyroid Hormone Market Size (M USD) by Application (2019-2024)
7.4 Global Recombinant Human Parathyroid Hormone Sales Growth Rate by Application (2019-2024)
8 RECOMBINANT HUMAN PARATHYROID HORMONE MARKET SEGMENTATION BY REGION
8.1 Global Recombinant Human Parathyroid Hormone Sales by Region
8.1.1 Global Recombinant Human Parathyroid Hormone Sales by Region
8.1.2 Global Recombinant Human Parathyroid Hormone Sales Market Share by Region
8.2 North America
8.2.1 North America Recombinant Human Parathyroid Hormone Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Recombinant Human Parathyroid Hormone Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Recombinant Human Parathyroid Hormone Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Recombinant Human Parathyroid Hormone Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Recombinant Human Parathyroid Hormone Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 NPS Pharma(Shire)
9.1.1 NPS Pharma(Shire) Recombinant Human Parathyroid Hormone Basic Information
9.1.2 NPS Pharma(Shire) Recombinant Human Parathyroid Hormone Product Overview
9.1.3 NPS Pharma(Shire) Recombinant Human Parathyroid Hormone Product Market Performance
9.1.4 NPS Pharma(Shire) Business Overview
9.1.5 NPS Pharma(Shire) Recombinant Human Parathyroid Hormone SWOT Analysis
9.1.6 NPS Pharma(Shire) Recent Developments
9.2 Takeda
9.2.1 Takeda Recombinant Human Parathyroid Hormone Basic Information
9.2.2 Takeda Recombinant Human Parathyroid Hormone Product Overview
9.2.3 Takeda Recombinant Human Parathyroid Hormone Product Market Performance
9.2.4 Takeda Business Overview
9.2.5 Takeda Recombinant Human Parathyroid Hormone SWOT Analysis
9.2.6 Takeda Recent Developments
9.3 Shandong Buchang Pharmaceuticals
9.3.1 Shandong Buchang Pharmaceuticals Recombinant Human Parathyroid Hormone Basic Information
9.3.2 Shandong Buchang Pharmaceuticals Recombinant Human Parathyroid Hormone Product Overview
9.3.3 Shandong Buchang Pharmaceuticals Recombinant Human Parathyroid Hormone Product Market Performance
9.3.4 Shandong Buchang Pharmaceuticals Recombinant Human Parathyroid Hormone SWOT Analysis
9.3.5 Shandong Buchang Pharmaceuticals Business Overview
9.3.6 Shandong Buchang Pharmaceuticals Recent Developments
9.4 Ascendis Pharma
9.4.1 Ascendis Pharma Recombinant Human Parathyroid Hormone Basic Information
9.4.2 Ascendis Pharma Recombinant Human Parathyroid Hormone Product Overview
9.4.3 Ascendis Pharma Recombinant Human Parathyroid Hormone Product Market Performance
9.4.4 Ascendis Pharma Business Overview
9.4.5 Ascendis Pharma Recent Developments
9.5 Beijing SL Pharmaceutical
9.5.1 Beijing SL Pharmaceutical Recombinant Human Parathyroid Hormone Basic Information
9.5.2 Beijing SL Pharmaceutical Recombinant Human Parathyroid Hormone Product Overview
9.5.3 Beijing SL Pharmaceutical Recombinant Human Parathyroid Hormone Product Market Performance
9.5.4 Beijing SL Pharmaceutical Business Overview
9.5.5 Beijing SL Pharmaceutical Recent Developments
10 RECOMBINANT HUMAN PARATHYROID HORMONE MARKET FORECAST BY REGION
10.1 Global Recombinant Human Parathyroid Hormone Market Size Forecast
10.2 Global Recombinant Human Parathyroid Hormone Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Recombinant Human Parathyroid Hormone Market Size Forecast by Country
10.2.3 Asia Pacific Recombinant Human Parathyroid Hormone Market Size Forecast by Region
10.2.4 South America Recombinant Human Parathyroid Hormone Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Recombinant Human Parathyroid Hormone by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Recombinant Human Parathyroid Hormone Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Recombinant Human Parathyroid Hormone by Type (2025-2030)
11.1.2 Global Recombinant Human Parathyroid Hormone Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Recombinant Human Parathyroid Hormone by Type (2025-2030)
11.2 Global Recombinant Human Parathyroid Hormone Market Forecast by Application (2025-2030)
11.2.1 Global Recombinant Human Parathyroid Hormone Sales (Kilotons) Forecast by Application
11.2.2 Global Recombinant Human Parathyroid Hormone Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Recombinant Human Parathyroid Hormone
1.2 Key Market Segments
1.2.1 Recombinant Human Parathyroid Hormone Segment by Type
1.2.2 Recombinant Human Parathyroid Hormone Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 RECOMBINANT HUMAN PARATHYROID HORMONE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Recombinant Human Parathyroid Hormone Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Recombinant Human Parathyroid Hormone Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 RECOMBINANT HUMAN PARATHYROID HORMONE MARKET COMPETITIVE LANDSCAPE
3.1 Global Recombinant Human Parathyroid Hormone Sales by Manufacturers (2019-2024)
3.2 Global Recombinant Human Parathyroid Hormone Revenue Market Share by Manufacturers (2019-2024)
3.3 Recombinant Human Parathyroid Hormone Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Recombinant Human Parathyroid Hormone Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Recombinant Human Parathyroid Hormone Sales Sites, Area Served, Product Type
3.6 Recombinant Human Parathyroid Hormone Market Competitive Situation and Trends
3.6.1 Recombinant Human Parathyroid Hormone Market Concentration Rate
3.6.2 Global 5 and 10 Largest Recombinant Human Parathyroid Hormone Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 RECOMBINANT HUMAN PARATHYROID HORMONE INDUSTRY CHAIN ANALYSIS
4.1 Recombinant Human Parathyroid Hormone Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF RECOMBINANT HUMAN PARATHYROID HORMONE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 RECOMBINANT HUMAN PARATHYROID HORMONE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Recombinant Human Parathyroid Hormone Sales Market Share by Type (2019-2024)
6.3 Global Recombinant Human Parathyroid Hormone Market Size Market Share by Type (2019-2024)
6.4 Global Recombinant Human Parathyroid Hormone Price by Type (2019-2024)
7 RECOMBINANT HUMAN PARATHYROID HORMONE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Recombinant Human Parathyroid Hormone Market Sales by Application (2019-2024)
7.3 Global Recombinant Human Parathyroid Hormone Market Size (M USD) by Application (2019-2024)
7.4 Global Recombinant Human Parathyroid Hormone Sales Growth Rate by Application (2019-2024)
8 RECOMBINANT HUMAN PARATHYROID HORMONE MARKET SEGMENTATION BY REGION
8.1 Global Recombinant Human Parathyroid Hormone Sales by Region
8.1.1 Global Recombinant Human Parathyroid Hormone Sales by Region
8.1.2 Global Recombinant Human Parathyroid Hormone Sales Market Share by Region
8.2 North America
8.2.1 North America Recombinant Human Parathyroid Hormone Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Recombinant Human Parathyroid Hormone Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Recombinant Human Parathyroid Hormone Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Recombinant Human Parathyroid Hormone Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Recombinant Human Parathyroid Hormone Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 NPS Pharma(Shire)
9.1.1 NPS Pharma(Shire) Recombinant Human Parathyroid Hormone Basic Information
9.1.2 NPS Pharma(Shire) Recombinant Human Parathyroid Hormone Product Overview
9.1.3 NPS Pharma(Shire) Recombinant Human Parathyroid Hormone Product Market Performance
9.1.4 NPS Pharma(Shire) Business Overview
9.1.5 NPS Pharma(Shire) Recombinant Human Parathyroid Hormone SWOT Analysis
9.1.6 NPS Pharma(Shire) Recent Developments
9.2 Takeda
9.2.1 Takeda Recombinant Human Parathyroid Hormone Basic Information
9.2.2 Takeda Recombinant Human Parathyroid Hormone Product Overview
9.2.3 Takeda Recombinant Human Parathyroid Hormone Product Market Performance
9.2.4 Takeda Business Overview
9.2.5 Takeda Recombinant Human Parathyroid Hormone SWOT Analysis
9.2.6 Takeda Recent Developments
9.3 Shandong Buchang Pharmaceuticals
9.3.1 Shandong Buchang Pharmaceuticals Recombinant Human Parathyroid Hormone Basic Information
9.3.2 Shandong Buchang Pharmaceuticals Recombinant Human Parathyroid Hormone Product Overview
9.3.3 Shandong Buchang Pharmaceuticals Recombinant Human Parathyroid Hormone Product Market Performance
9.3.4 Shandong Buchang Pharmaceuticals Recombinant Human Parathyroid Hormone SWOT Analysis
9.3.5 Shandong Buchang Pharmaceuticals Business Overview
9.3.6 Shandong Buchang Pharmaceuticals Recent Developments
9.4 Ascendis Pharma
9.4.1 Ascendis Pharma Recombinant Human Parathyroid Hormone Basic Information
9.4.2 Ascendis Pharma Recombinant Human Parathyroid Hormone Product Overview
9.4.3 Ascendis Pharma Recombinant Human Parathyroid Hormone Product Market Performance
9.4.4 Ascendis Pharma Business Overview
9.4.5 Ascendis Pharma Recent Developments
9.5 Beijing SL Pharmaceutical
9.5.1 Beijing SL Pharmaceutical Recombinant Human Parathyroid Hormone Basic Information
9.5.2 Beijing SL Pharmaceutical Recombinant Human Parathyroid Hormone Product Overview
9.5.3 Beijing SL Pharmaceutical Recombinant Human Parathyroid Hormone Product Market Performance
9.5.4 Beijing SL Pharmaceutical Business Overview
9.5.5 Beijing SL Pharmaceutical Recent Developments
10 RECOMBINANT HUMAN PARATHYROID HORMONE MARKET FORECAST BY REGION
10.1 Global Recombinant Human Parathyroid Hormone Market Size Forecast
10.2 Global Recombinant Human Parathyroid Hormone Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Recombinant Human Parathyroid Hormone Market Size Forecast by Country
10.2.3 Asia Pacific Recombinant Human Parathyroid Hormone Market Size Forecast by Region
10.2.4 South America Recombinant Human Parathyroid Hormone Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Recombinant Human Parathyroid Hormone by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Recombinant Human Parathyroid Hormone Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Recombinant Human Parathyroid Hormone by Type (2025-2030)
11.1.2 Global Recombinant Human Parathyroid Hormone Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Recombinant Human Parathyroid Hormone by Type (2025-2030)
11.2 Global Recombinant Human Parathyroid Hormone Market Forecast by Application (2025-2030)
11.2.1 Global Recombinant Human Parathyroid Hormone Sales (Kilotons) Forecast by Application
11.2.2 Global Recombinant Human Parathyroid Hormone Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Recombinant Human Parathyroid Hormone Market Size Comparison by Region (M USD)
Table 5. Global Recombinant Human Parathyroid Hormone Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Recombinant Human Parathyroid Hormone Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Recombinant Human Parathyroid Hormone Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Recombinant Human Parathyroid Hormone Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Human Parathyroid Hormone as of 2022)
Table 10. Global Market Recombinant Human Parathyroid Hormone Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Recombinant Human Parathyroid Hormone Sales Sites and Area Served
Table 12. Manufacturers Recombinant Human Parathyroid Hormone Product Type
Table 13. Global Recombinant Human Parathyroid Hormone Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Recombinant Human Parathyroid Hormone
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Recombinant Human Parathyroid Hormone Market Challenges
Table 22. Global Recombinant Human Parathyroid Hormone Sales by Type (Kilotons)
Table 23. Global Recombinant Human Parathyroid Hormone Market Size by Type (M USD)
Table 24. Global Recombinant Human Parathyroid Hormone Sales (Kilotons) by Type (2019-2024)
Table 25. Global Recombinant Human Parathyroid Hormone Sales Market Share by Type (2019-2024)
Table 26. Global Recombinant Human Parathyroid Hormone Market Size (M USD) by Type (2019-2024)
Table 27. Global Recombinant Human Parathyroid Hormone Market Size Share by Type (2019-2024)
Table 28. Global Recombinant Human Parathyroid Hormone Price (USD/Ton) by Type (2019-2024)
Table 29. Global Recombinant Human Parathyroid Hormone Sales (Kilotons) by Application
Table 30. Global Recombinant Human Parathyroid Hormone Market Size by Application
Table 31. Global Recombinant Human Parathyroid Hormone Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Recombinant Human Parathyroid Hormone Sales Market Share by Application (2019-2024)
Table 33. Global Recombinant Human Parathyroid Hormone Sales by Application (2019-2024) & (M USD)
Table 34. Global Recombinant Human Parathyroid Hormone Market Share by Application (2019-2024)
Table 35. Global Recombinant Human Parathyroid Hormone Sales Growth Rate by Application (2019-2024)
Table 36. Global Recombinant Human Parathyroid Hormone Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Recombinant Human Parathyroid Hormone Sales Market Share by Region (2019-2024)
Table 38. North America Recombinant Human Parathyroid Hormone Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Recombinant Human Parathyroid Hormone Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Recombinant Human Parathyroid Hormone Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Recombinant Human Parathyroid Hormone Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Recombinant Human Parathyroid Hormone Sales by Region (2019-2024) & (Kilotons)
Table 43. NPS Pharma(Shire) Recombinant Human Parathyroid Hormone Basic Information
Table 44. NPS Pharma(Shire) Recombinant Human Parathyroid Hormone Product Overview
Table 45. NPS Pharma(Shire) Recombinant Human Parathyroid Hormone Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. NPS Pharma(Shire) Business Overview
Table 47. NPS Pharma(Shire) Recombinant Human Parathyroid Hormone SWOT Analysis
Table 48. NPS Pharma(Shire) Recent Developments
Table 49. Takeda Recombinant Human Parathyroid Hormone Basic Information
Table 50. Takeda Recombinant Human Parathyroid Hormone Product Overview
Table 51. Takeda Recombinant Human Parathyroid Hormone Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Takeda Business Overview
Table 53. Takeda Recombinant Human Parathyroid Hormone SWOT Analysis
Table 54. Takeda Recent Developments
Table 55. Shandong Buchang Pharmaceuticals Recombinant Human Parathyroid Hormone Basic Information
Table 56. Shandong Buchang Pharmaceuticals Recombinant Human Parathyroid Hormone Product Overview
Table 57. Shandong Buchang Pharmaceuticals Recombinant Human Parathyroid Hormone Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Shandong Buchang Pharmaceuticals Recombinant Human Parathyroid Hormone SWOT Analysis
Table 59. Shandong Buchang Pharmaceuticals Business Overview
Table 60. Shandong Buchang Pharmaceuticals Recent Developments
Table 61. Ascendis Pharma Recombinant Human Parathyroid Hormone Basic Information
Table 62. Ascendis Pharma Recombinant Human Parathyroid Hormone Product Overview
Table 63. Ascendis Pharma Recombinant Human Parathyroid Hormone Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Ascendis Pharma Business Overview
Table 65. Ascendis Pharma Recent Developments
Table 66. Beijing SL Pharmaceutical Recombinant Human Parathyroid Hormone Basic Information
Table 67. Beijing SL Pharmaceutical Recombinant Human Parathyroid Hormone Product Overview
Table 68. Beijing SL Pharmaceutical Recombinant Human Parathyroid Hormone Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Beijing SL Pharmaceutical Business Overview
Table 70. Beijing SL Pharmaceutical Recent Developments
Table 71. Global Recombinant Human Parathyroid Hormone Sales Forecast by Region (2025-2030) & (Kilotons)
Table 72. Global Recombinant Human Parathyroid Hormone Market Size Forecast by Region (2025-2030) & (M USD)
Table 73. North America Recombinant Human Parathyroid Hormone Sales Forecast by Country (2025-2030) & (Kilotons)
Table 74. North America Recombinant Human Parathyroid Hormone Market Size Forecast by Country (2025-2030) & (M USD)
Table 75. Europe Recombinant Human Parathyroid Hormone Sales Forecast by Country (2025-2030) & (Kilotons)
Table 76. Europe Recombinant Human Parathyroid Hormone Market Size Forecast by Country (2025-2030) & (M USD)
Table 77. Asia Pacific Recombinant Human Parathyroid Hormone Sales Forecast by Region (2025-2030) & (Kilotons)
Table 78. Asia Pacific Recombinant Human Parathyroid Hormone Market Size Forecast by Region (2025-2030) & (M USD)
Table 79. South America Recombinant Human Parathyroid Hormone Sales Forecast by Country (2025-2030) & (Kilotons)
Table 80. South America Recombinant Human Parathyroid Hormone Market Size Forecast by Country (2025-2030) & (M USD)
Table 81. Middle East and Africa Recombinant Human Parathyroid Hormone Consumption Forecast by Country (2025-2030) & (Units)
Table 82. Middle East and Africa Recombinant Human Parathyroid Hormone Market Size Forecast by Country (2025-2030) & (M USD)
Table 83. Global Recombinant Human Parathyroid Hormone Sales Forecast by Type (2025-2030) & (Kilotons)
Table 84. Global Recombinant Human Parathyroid Hormone Market Size Forecast by Type (2025-2030) & (M USD)
Table 85. Global Recombinant Human Parathyroid Hormone Price Forecast by Type (2025-2030) & (USD/Ton)
Table 86. Global Recombinant Human Parathyroid Hormone Sales (Kilotons) Forecast by Application (2025-2030)
Table 87. Global Recombinant Human Parathyroid Hormone Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Recombinant Human Parathyroid Hormone Market Size Comparison by Region (M USD)
Table 5. Global Recombinant Human Parathyroid Hormone Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Recombinant Human Parathyroid Hormone Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Recombinant Human Parathyroid Hormone Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Recombinant Human Parathyroid Hormone Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Human Parathyroid Hormone as of 2022)
Table 10. Global Market Recombinant Human Parathyroid Hormone Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Recombinant Human Parathyroid Hormone Sales Sites and Area Served
Table 12. Manufacturers Recombinant Human Parathyroid Hormone Product Type
Table 13. Global Recombinant Human Parathyroid Hormone Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Recombinant Human Parathyroid Hormone
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Recombinant Human Parathyroid Hormone Market Challenges
Table 22. Global Recombinant Human Parathyroid Hormone Sales by Type (Kilotons)
Table 23. Global Recombinant Human Parathyroid Hormone Market Size by Type (M USD)
Table 24. Global Recombinant Human Parathyroid Hormone Sales (Kilotons) by Type (2019-2024)
Table 25. Global Recombinant Human Parathyroid Hormone Sales Market Share by Type (2019-2024)
Table 26. Global Recombinant Human Parathyroid Hormone Market Size (M USD) by Type (2019-2024)
Table 27. Global Recombinant Human Parathyroid Hormone Market Size Share by Type (2019-2024)
Table 28. Global Recombinant Human Parathyroid Hormone Price (USD/Ton) by Type (2019-2024)
Table 29. Global Recombinant Human Parathyroid Hormone Sales (Kilotons) by Application
Table 30. Global Recombinant Human Parathyroid Hormone Market Size by Application
Table 31. Global Recombinant Human Parathyroid Hormone Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Recombinant Human Parathyroid Hormone Sales Market Share by Application (2019-2024)
Table 33. Global Recombinant Human Parathyroid Hormone Sales by Application (2019-2024) & (M USD)
Table 34. Global Recombinant Human Parathyroid Hormone Market Share by Application (2019-2024)
Table 35. Global Recombinant Human Parathyroid Hormone Sales Growth Rate by Application (2019-2024)
Table 36. Global Recombinant Human Parathyroid Hormone Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Recombinant Human Parathyroid Hormone Sales Market Share by Region (2019-2024)
Table 38. North America Recombinant Human Parathyroid Hormone Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Recombinant Human Parathyroid Hormone Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Recombinant Human Parathyroid Hormone Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Recombinant Human Parathyroid Hormone Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Recombinant Human Parathyroid Hormone Sales by Region (2019-2024) & (Kilotons)
Table 43. NPS Pharma(Shire) Recombinant Human Parathyroid Hormone Basic Information
Table 44. NPS Pharma(Shire) Recombinant Human Parathyroid Hormone Product Overview
Table 45. NPS Pharma(Shire) Recombinant Human Parathyroid Hormone Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. NPS Pharma(Shire) Business Overview
Table 47. NPS Pharma(Shire) Recombinant Human Parathyroid Hormone SWOT Analysis
Table 48. NPS Pharma(Shire) Recent Developments
Table 49. Takeda Recombinant Human Parathyroid Hormone Basic Information
Table 50. Takeda Recombinant Human Parathyroid Hormone Product Overview
Table 51. Takeda Recombinant Human Parathyroid Hormone Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Takeda Business Overview
Table 53. Takeda Recombinant Human Parathyroid Hormone SWOT Analysis
Table 54. Takeda Recent Developments
Table 55. Shandong Buchang Pharmaceuticals Recombinant Human Parathyroid Hormone Basic Information
Table 56. Shandong Buchang Pharmaceuticals Recombinant Human Parathyroid Hormone Product Overview
Table 57. Shandong Buchang Pharmaceuticals Recombinant Human Parathyroid Hormone Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Shandong Buchang Pharmaceuticals Recombinant Human Parathyroid Hormone SWOT Analysis
Table 59. Shandong Buchang Pharmaceuticals Business Overview
Table 60. Shandong Buchang Pharmaceuticals Recent Developments
Table 61. Ascendis Pharma Recombinant Human Parathyroid Hormone Basic Information
Table 62. Ascendis Pharma Recombinant Human Parathyroid Hormone Product Overview
Table 63. Ascendis Pharma Recombinant Human Parathyroid Hormone Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Ascendis Pharma Business Overview
Table 65. Ascendis Pharma Recent Developments
Table 66. Beijing SL Pharmaceutical Recombinant Human Parathyroid Hormone Basic Information
Table 67. Beijing SL Pharmaceutical Recombinant Human Parathyroid Hormone Product Overview
Table 68. Beijing SL Pharmaceutical Recombinant Human Parathyroid Hormone Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Beijing SL Pharmaceutical Business Overview
Table 70. Beijing SL Pharmaceutical Recent Developments
Table 71. Global Recombinant Human Parathyroid Hormone Sales Forecast by Region (2025-2030) & (Kilotons)
Table 72. Global Recombinant Human Parathyroid Hormone Market Size Forecast by Region (2025-2030) & (M USD)
Table 73. North America Recombinant Human Parathyroid Hormone Sales Forecast by Country (2025-2030) & (Kilotons)
Table 74. North America Recombinant Human Parathyroid Hormone Market Size Forecast by Country (2025-2030) & (M USD)
Table 75. Europe Recombinant Human Parathyroid Hormone Sales Forecast by Country (2025-2030) & (Kilotons)
Table 76. Europe Recombinant Human Parathyroid Hormone Market Size Forecast by Country (2025-2030) & (M USD)
Table 77. Asia Pacific Recombinant Human Parathyroid Hormone Sales Forecast by Region (2025-2030) & (Kilotons)
Table 78. Asia Pacific Recombinant Human Parathyroid Hormone Market Size Forecast by Region (2025-2030) & (M USD)
Table 79. South America Recombinant Human Parathyroid Hormone Sales Forecast by Country (2025-2030) & (Kilotons)
Table 80. South America Recombinant Human Parathyroid Hormone Market Size Forecast by Country (2025-2030) & (M USD)
Table 81. Middle East and Africa Recombinant Human Parathyroid Hormone Consumption Forecast by Country (2025-2030) & (Units)
Table 82. Middle East and Africa Recombinant Human Parathyroid Hormone Market Size Forecast by Country (2025-2030) & (M USD)
Table 83. Global Recombinant Human Parathyroid Hormone Sales Forecast by Type (2025-2030) & (Kilotons)
Table 84. Global Recombinant Human Parathyroid Hormone Market Size Forecast by Type (2025-2030) & (M USD)
Table 85. Global Recombinant Human Parathyroid Hormone Price Forecast by Type (2025-2030) & (USD/Ton)
Table 86. Global Recombinant Human Parathyroid Hormone Sales (Kilotons) Forecast by Application (2025-2030)
Table 87. Global Recombinant Human Parathyroid Hormone Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Recombinant Human Parathyroid Hormone
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Recombinant Human Parathyroid Hormone Market Size (M USD), 2019-2030
Figure 5. Global Recombinant Human Parathyroid Hormone Market Size (M USD) (2019-2030)
Figure 6. Global Recombinant Human Parathyroid Hormone Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Recombinant Human Parathyroid Hormone Market Size by Country (M USD)
Figure 11. Recombinant Human Parathyroid Hormone Sales Share by Manufacturers in 2023
Figure 12. Global Recombinant Human Parathyroid Hormone Revenue Share by Manufacturers in 2023
Figure 13. Recombinant Human Parathyroid Hormone Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Recombinant Human Parathyroid Hormone Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Recombinant Human Parathyroid Hormone Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Recombinant Human Parathyroid Hormone Market Share by Type
Figure 18. Sales Market Share of Recombinant Human Parathyroid Hormone by Type (2019-2024)
Figure 19. Sales Market Share of Recombinant Human Parathyroid Hormone by Type in 2023
Figure 20. Market Size Share of Recombinant Human Parathyroid Hormone by Type (2019-2024)
Figure 21. Market Size Market Share of Recombinant Human Parathyroid Hormone by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Recombinant Human Parathyroid Hormone Market Share by Application
Figure 24. Global Recombinant Human Parathyroid Hormone Sales Market Share by Application (2019-2024)
Figure 25. Global Recombinant Human Parathyroid Hormone Sales Market Share by Application in 2023
Figure 26. Global Recombinant Human Parathyroid Hormone Market Share by Application (2019-2024)
Figure 27. Global Recombinant Human Parathyroid Hormone Market Share by Application in 2023
Figure 28. Global Recombinant Human Parathyroid Hormone Sales Growth Rate by Application (2019-2024)
Figure 29. Global Recombinant Human Parathyroid Hormone Sales Market Share by Region (2019-2024)
Figure 30. North America Recombinant Human Parathyroid Hormone Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Recombinant Human Parathyroid Hormone Sales Market Share by Country in 2023
Figure 32. U.S. Recombinant Human Parathyroid Hormone Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Recombinant Human Parathyroid Hormone Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Recombinant Human Parathyroid Hormone Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Recombinant Human Parathyroid Hormone Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Recombinant Human Parathyroid Hormone Sales Market Share by Country in 2023
Figure 37. Germany Recombinant Human Parathyroid Hormone Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Recombinant Human Parathyroid Hormone Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Recombinant Human Parathyroid Hormone Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Recombinant Human Parathyroid Hormone Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Recombinant Human Parathyroid Hormone Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Recombinant Human Parathyroid Hormone Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Recombinant Human Parathyroid Hormone Sales Market Share by Region in 2023
Figure 44. China Recombinant Human Parathyroid Hormone Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Recombinant Human Parathyroid Hormone Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Recombinant Human Parathyroid Hormone Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Recombinant Human Parathyroid Hormone Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Recombinant Human Parathyroid Hormone Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Recombinant Human Parathyroid Hormone Sales and Growth Rate (Kilotons)
Figure 50. South America Recombinant Human Parathyroid Hormone Sales Market Share by Country in 2023
Figure 51. Brazil Recombinant Human Parathyroid Hormone Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Recombinant Human Parathyroid Hormone Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Recombinant Human Parathyroid Hormone Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Recombinant Human Parathyroid Hormone Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Recombinant Human Parathyroid Hormone Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Recombinant Human Parathyroid Hormone Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Recombinant Human Parathyroid Hormone Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Recombinant Human Parathyroid Hormone Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Recombinant Human Parathyroid Hormone Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Recombinant Human Parathyroid Hormone Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Recombinant Human Parathyroid Hormone Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Recombinant Human Parathyroid Hormone Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Recombinant Human Parathyroid Hormone Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Recombinant Human Parathyroid Hormone Market Share Forecast by Type (2025-2030)
Figure 65. Global Recombinant Human Parathyroid Hormone Sales Forecast by Application (2025-2030)
Figure 66. Global Recombinant Human Parathyroid Hormone Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Recombinant Human Parathyroid Hormone
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Recombinant Human Parathyroid Hormone Market Size (M USD), 2019-2030
Figure 5. Global Recombinant Human Parathyroid Hormone Market Size (M USD) (2019-2030)
Figure 6. Global Recombinant Human Parathyroid Hormone Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Recombinant Human Parathyroid Hormone Market Size by Country (M USD)
Figure 11. Recombinant Human Parathyroid Hormone Sales Share by Manufacturers in 2023
Figure 12. Global Recombinant Human Parathyroid Hormone Revenue Share by Manufacturers in 2023
Figure 13. Recombinant Human Parathyroid Hormone Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Recombinant Human Parathyroid Hormone Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Recombinant Human Parathyroid Hormone Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Recombinant Human Parathyroid Hormone Market Share by Type
Figure 18. Sales Market Share of Recombinant Human Parathyroid Hormone by Type (2019-2024)
Figure 19. Sales Market Share of Recombinant Human Parathyroid Hormone by Type in 2023
Figure 20. Market Size Share of Recombinant Human Parathyroid Hormone by Type (2019-2024)
Figure 21. Market Size Market Share of Recombinant Human Parathyroid Hormone by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Recombinant Human Parathyroid Hormone Market Share by Application
Figure 24. Global Recombinant Human Parathyroid Hormone Sales Market Share by Application (2019-2024)
Figure 25. Global Recombinant Human Parathyroid Hormone Sales Market Share by Application in 2023
Figure 26. Global Recombinant Human Parathyroid Hormone Market Share by Application (2019-2024)
Figure 27. Global Recombinant Human Parathyroid Hormone Market Share by Application in 2023
Figure 28. Global Recombinant Human Parathyroid Hormone Sales Growth Rate by Application (2019-2024)
Figure 29. Global Recombinant Human Parathyroid Hormone Sales Market Share by Region (2019-2024)
Figure 30. North America Recombinant Human Parathyroid Hormone Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Recombinant Human Parathyroid Hormone Sales Market Share by Country in 2023
Figure 32. U.S. Recombinant Human Parathyroid Hormone Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Recombinant Human Parathyroid Hormone Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Recombinant Human Parathyroid Hormone Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Recombinant Human Parathyroid Hormone Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Recombinant Human Parathyroid Hormone Sales Market Share by Country in 2023
Figure 37. Germany Recombinant Human Parathyroid Hormone Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Recombinant Human Parathyroid Hormone Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Recombinant Human Parathyroid Hormone Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Recombinant Human Parathyroid Hormone Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Recombinant Human Parathyroid Hormone Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Recombinant Human Parathyroid Hormone Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Recombinant Human Parathyroid Hormone Sales Market Share by Region in 2023
Figure 44. China Recombinant Human Parathyroid Hormone Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Recombinant Human Parathyroid Hormone Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Recombinant Human Parathyroid Hormone Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Recombinant Human Parathyroid Hormone Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Recombinant Human Parathyroid Hormone Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Recombinant Human Parathyroid Hormone Sales and Growth Rate (Kilotons)
Figure 50. South America Recombinant Human Parathyroid Hormone Sales Market Share by Country in 2023
Figure 51. Brazil Recombinant Human Parathyroid Hormone Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Recombinant Human Parathyroid Hormone Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Recombinant Human Parathyroid Hormone Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Recombinant Human Parathyroid Hormone Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Recombinant Human Parathyroid Hormone Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Recombinant Human Parathyroid Hormone Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Recombinant Human Parathyroid Hormone Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Recombinant Human Parathyroid Hormone Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Recombinant Human Parathyroid Hormone Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Recombinant Human Parathyroid Hormone Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Recombinant Human Parathyroid Hormone Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Recombinant Human Parathyroid Hormone Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Recombinant Human Parathyroid Hormone Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Recombinant Human Parathyroid Hormone Market Share Forecast by Type (2025-2030)
Figure 65. Global Recombinant Human Parathyroid Hormone Sales Forecast by Application (2025-2030)
Figure 66. Global Recombinant Human Parathyroid Hormone Market Share Forecast by Application (2025-2030)
